Overview

Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
To investigate the therapeutic effect of individualized treatment of antiplatelet in secondary prevention of ischemic stroke.
Phase:
Phase 1
Details
Lead Sponsor:
Xuanwu Hospital, Beijing
Collaborators:
Chinese PLA General Hospital
Peking University People's Hospital